Trip.com Group Limited Securities Fraud Class Action Result of Antitrust Probe and 19% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / March 16, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until May 11, 2026 to file lead plaintiff applications in a securities class […]

BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK, NY AND NEW ORLEANS, LA / ACCESS Newswire / March 16, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 23, 2026 to file lead plaintiff applications in a securities class action

Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / March 16, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE:KD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit

Driven Brands Holdings Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and 39% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / March 16, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until May 8, 2026 to file lead plaintiff applications in a securities class

Apollo Global Management, Inc. Securities Fraud Class Action Result of Undisclosed Relationship with Jeffrey Epstein and 16% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / March 16, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until May 1, 2026 to file lead plaintiff applications in a securities class

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages ODDITY Tech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ODD

NEW YORK CITY, NY / ACCESS Newswire / March 16, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ODDITY Tech Ltd. (NASDAQ:ODD) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period"). A class action lawsuit has

PLUG DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PLUG

NEW YORK CITY, NY / ACCESS Newswire / March 16, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Plug Power Inc. (NASDAQ:PLUG) between January 17, 2025 and November 13, 2025, inclusive (the "Class Period"), of the important April 3, 2026 lead plaintiff deadline. SO WHAT: If

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Babcock & Wilcox Enterprises, Inc. – BW

NEW YORK CITY, NY / ACCESS Newswire / March 16, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE:BW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether B&W and certain of its

Andrew Hamilton Acquires Omeprazole.com From AstraZeneca, Expanding Strategic Pharmaceutical Domain Portfolio

GRANTS PASS, OR / ACCESS Newswire / March 16, 2026 / Venture capitalist and biotech entrepreneur Andrew Hamilton, through his investment firm Pale Horse Capital, has acquired the premium pharmaceutical domain Omeprazole.com from global drugmaker AstraZeneca, marking a rare transfer of digital infrastructure tied directly to one of the most widely recognized pharmaceutical compounds in

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited – IMMP

NEW YORK CITY, NY / ACCESS Newswire / March 16, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ:IMMP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Immutep and certain of its officers and/or directors

Scroll to Top